Docosahexaenoic acid in plasma phosphatidylcholine may be a potential marker for in vivo phosphatidylethanolamine N-methyltransferase activity in humans

Background: Choline is an essential nutrient for humans, and part of this requirement is met by endogenous synthesis catalyzed by hepatic phosphatidylethanolamine N-methyltransferase (PEMT). PEMT activity is difficult to estimate in humans because it requires a liver biopsy. Previously, we showed th...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of clinical nutrition Vol. 93; no. 5; pp. 968 - 974
Main Authors da Costa, Kerry-Ann, Sanders, Lisa M, Fischer, Leslie M, Zeisel, Steven H
Format Journal Article
LanguageEnglish
Published Bethesda, MD Elsevier Inc 01.05.2011
American Society for Nutrition
American Society for Clinical Nutrition, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: Choline is an essential nutrient for humans, and part of this requirement is met by endogenous synthesis catalyzed by hepatic phosphatidylethanolamine N-methyltransferase (PEMT). PEMT activity is difficult to estimate in humans because it requires a liver biopsy. Previously, we showed that mice that lack functional PEMT have dramatically reduced concentrations of docosahexaenoic acid (DHA; 22:6n−3) in plasma and of liver phosphatidylcholine (PtdCho)—a phospholipid formed by PEMT. Objective: The objective was to evaluate plasma PtdCho-DHA concentrations as a noninvasive marker of liver PEMT activity in humans. Design: Plasma PtdCho-DHA concentrations were measured in 72 humans before and after they consumed a low-choline diet, and correlations were analyzed in relation to estrogen status, PEMT polymorphism rs12325817, the ratio of plasma S-adenosylmethionine (AdoMet) to S-adenosylhomocysteine (AdoHcy), and dietary choline intake; all of these factors are associated with changes in liver PEMT activity. PtdCho-DHA and PEMT activity were also measured in human liver specimens. Results: At baseline, the portion of PtdCho species containing DHA (pmol PtdCho-DHA/nmol PtdCho) was higher in premenopausal women than in men and postmenopausal women (P < 0.01). This ratio was lower in premenopausal women with the rs12325817 polymorphism in the PEMT gene (P < 0.05), and PtdCho-DHA concentration and PEMT activity were lower in human liver samples from women who were homozygous for PEMT rs12325817 (P < 0.05). The ratio of DHA-PtdCho to PtdCho in plasma was directly correlated with the ratio of AdoMet to AdoHcy (P = 0.0001). The portion of PtdCho species containing DHA in plasma was altered in subjects who consumed a low-choline diet. Conclusion: PtdCho-DHA may be useful as a surrogate marker for in vivo hepatic PEMT activity in humans. This trial was registered at clinicaltrials.gov as NCT00065546.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Supported by a grant from the National Institutes of Health (DK55865) and grants from the National Institutes of Health to the University of North Carolina Nutrition and Obesity Research Center (DK56350) and Clinical and Translational Research Center (M01RR00046 and UL1RR025747). The Solae Company provided the ingredients used to formulate the diets.
ISSN:0002-9165
1938-3207
1938-3207
DOI:10.3945/ajcn.110.011064